Perioperative bridging with fondaparinux in a woman with antithrombin deficiency

被引：10

作者：

Bauersachs, Rupert

Alban, Susanne

机构：

[1] Klinikum Darmstadt, Med Dept Vasc Med 4, Med Klin 4, D-64297 Darmstadt, Germany

[2] Univ Kiel, Inst Pharmazeut, Abt Pharmazeut Biol, Kiel, Germany

来源：

THROMBOSIS AND HAEMOSTASIS | 2007年 / 97卷 / 03期

关键词：

D O I：

10.1160/TH06-10-0598

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：498 / 499

页数：2

共 13 条

[1] Fixed dosage of low-molecular-weight heparins causes large individual variation in coagulability, only partly correlated to body weight [J].

Al Dieri, R ;

Alban, S ;

Bégun, S ;

Hemker, HC .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (01) :83-89

[2]

ANSELL J, 2005, CHEST, V127, P415

[3] Fondaparinux: a new synthetic and selective inhibitor of Factor Xa [J].

Bauer, KA .

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2004, 17 (01) :89-104

[4]

Béguin S, 1999, HAEMOSTASIS, V29, P170

[5] The pharmacokinetics of fondaparinux sodium in healthy volunteers [J].

Donat, F ;

Duret, JP ;

Santoni, A ;

Cariou, R ;

Necciari, J ;

Magnani, H ;

de Greef, R .

CLINICAL PHARMACOKINETICS, 2002, 41 (Suppl 2) :1-9

[6] Heparin and low-molecular-weight heparin - The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy [J].

Hirsh, J ;

Raschke, R .

CHEST, 2004, 126 (03) :188S-203S

[7] Heparin resistance and antithrombin: Should it still be called heparin resistance? [J].

Levy, JH .

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2004, 18 (02) :129-130

[8]

OLSON ST, 1992, J BIOL CHEM, V267, P12528

[9] Fondaparinux sodium mechanism of action -: Identification of specific binding to purified and human plasma-derived proteins [J].

Paolucci, F ;

Claviés, MC ;

Donat, F ;

Necciari, J .

CLINICAL PHARMACOKINETICS, 2002, 41 (Suppl 2) :11-18

[10]

Spyropoulos AC, 2005, CURR OPIN PULM MED, V11, P373

← 1 2 →